Cypralis Limited CAMBRIDGE


Founded in 2012, Cypralis, classified under reg no. 08028515 is an active company. Currently registered at St Johns Innovation Centre CB4 0WS, Cambridge the company has been in the business for 12 years. Its financial year was closed on Tue, 31st Dec and its latest financial statement was filed on December 31, 2022. Since October 17, 2013 Cypralis Limited is no longer carrying the name Selcia Pharma.

The company has 2 directors, namely Andreas R., Hans F.. Of them, Hans F. has been with the company the longest, being appointed on 12 April 2012 and Andreas R. has been with the company for the least time - from 1 July 2013. At present there are several former directors listed by the company. Their names might be found in the table below. In addition, there is one former secretary - Kerry W. who worked with the the company until 31 December 2017.

Cypralis Limited Address / Contact

Office Address St Johns Innovation Centre
Office Address2 Cowley Road
Town Cambridge
Post code CB4 0WS
Country of origin United Kingdom

Company Information / Profile

Registration Number 08028515
Date of Incorporation Thu, 12th Apr 2012
Industry Research and experimental development on biotechnology
End of financial Year 31st December
Company age 12 years old
Account next due date Mon, 30th Sep 2024 (139 days left)
Account last made up date Sat, 31st Dec 2022
Next confirmation statement due date Sun, 25th Aug 2024 (2024-08-25)
Last confirmation statement dated Fri, 11th Aug 2023

Company staff

Andreas R.

Position: Director

Appointed: 01 July 2013

Hans F.

Position: Director

Appointed: 12 April 2012

Nicola B.

Position: Director

Appointed: 27 November 2014

Resigned: 12 May 2023

Simon K.

Position: Director

Appointed: 01 October 2014

Resigned: 19 March 2019

Peter H.

Position: Director

Appointed: 11 March 2013

Resigned: 05 December 2017

Kerry W.

Position: Secretary

Appointed: 12 April 2012

Resigned: 31 December 2017

Simon S.

Position: Director

Appointed: 12 April 2012

Resigned: 28 February 2013

People with significant control

The register of persons with significant control that own or have control over the company is made up of 1 name. As we found, there is Hans F. This PSC and has 50,01-75% shares.

Hans F.

Notified on 6 April 2016
Nature of control: 50,01-75% shares

Company previous names

Selcia Pharma October 17, 2013

Company filings

Filing category
Accounts Address Annual return Capital Change of name Confirmation statement Incorporation Officers Resolution
Total exemption full company accounts data drawn up to December 31, 2022
filed on: 30th, August 2023
Free Download (10 pages)

Company search